Arseus/Fagron acquire US pharma compounder Freedom Pharma

USA-based Freedom Pharmaceuticals says that it has been acquired by Arseus, the holding company for Fagron, a global leader in pharmaceutical compounding based in the Netherlands. Freedom will immediately become a wholly owned subsidiary of Fagron. Financial terms were not disclosed.

Freedom Pharma, a privately held company located in Tulsa, Oklahoma, specializes in the custom wholesale distribution of fine compounding chemicals - active pharmaceutical ingredients (APIs) and excipients - to independent compounding pharmacies throughout the United States.

"I am looking forward to combining forces with the Fagron Group. Fagron’s global and rapidly expanding network offers great potential to roll out successful and unique products and concepts internationally,” said Jacob (Jake) Jackson, president of Freedom, adding: "Our clients will benefit from an excellent range of more than 1,500 high quality products and services, and our employees will enjoy opportunities for further development in an international environment.”